Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate gargle to prevent postoperative sore throat after laryngeal mask airway in gynecologic laparoscopy
ChiCTR2500097804Phase 4Not yet recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of magnesium sulfate in Post-extubation sore throat (POST) (4 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Postoperative sore throat. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on ChiCTR2500097804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097804.